One out of three adults is at risk of death. Scientists have discovered a new type of heart disease called CKM (cardiovascular kidney metabolic syndrome ) and others among kidney disease, metabolic disorders such as type 2 diabetes, characterized by severe pain and disease.
CKM syndrome can negatively affect almost every major organ in the body, including the heart, brain, kidneys, and liver, but most importantly the cardiovascular system. It affects blood vessels, heart muscles, and the rate of fat accumulation in the arteries.
CKM Syndrome Stages
CKM syndrome can be divided into three stages. Each is associated with specific challenges and therapies that prevent it from progressing to the next level.
People in Stage I are those who are big, especially with excess belly fat. Or those who suffer from glucose intolerance or who are victims of “ prediabetes”. To protect themselves from the specter of CKM, they are advised to lose 5% of their weight. Screening for two to three years is also recommended.
Stage II are those who have high blood pressure, type 2 diabetes, high triglycerides, or kidney disease. Therefore, to prevent the increase in health, doctors can prescribe medicines to control blood pressure, blood sugar, and cholesterol.
Patients may also be prescribed Ozempic or Wegovy for weight loss. Annual heart health and kidney function tests are recommended.
Stage III is considered early cardiovascular disease without Symptoms and includes people with signs of arterial disease or problems with heart function. Additional processing may be required in this regard.
The purpose of these stages is to give people a framework for the regression of “CKM Symptoms Regression” which means going down one level. These may include improvement in blood sugar control, cholesterol levels, blood pressure, weight, kidney function, and heart dysfunction.
Doctors are advised to encourage middle-aged patients with metabolic syndrome to have regular checkups. even if they feel well.
Middle-aged people with metabolic syndrome characterized by slightly increased waist circumference, blood pressure, cholesterol, and blood sugar, have heart attacks and strokes about two years earlier than their peers who do not have these risk factors.
Metabolic syndrome affects approximately 31% of the world’s population and is associated with an increased risk of diabetes, heart disease, stroke, and premature death.
With the increasing incidence of metabolic syndrome, addressing these risk factors early with preventive measures can significantly reduce the frequency of heart attacks, strokes, and related health complications.
CKM-related screening aims to detect early changes in cardiovascular, metabolic, and renal health; the barrier to social recognition and healthcare structures; and nonprogression to the next stage of CKM syndrome.
However, studies suggest that CKM syndrome is progressive and begins early in life.
This is the major reason it is most recommended that children and youth have their weight, blood pressure, and mental and behavioral health checked annually from an early stage.
Call For Action
We need fundamental changes in how we educate health professionals and the public, how we organize care on CKM, and how we pay for CKM care, partnership with key stakeholders are needed to improve access to therapies, support new forms of care, and people from diverse communities and circumstances to enable them to live healthier lives and achieve optimal cardiovascular health.
Also, research studies are important for advancing CKM care, and key research gaps. A better understanding of the pathways leading to heart disease in CKM syndrome.
It is better to understand why some people progress more quickly through the CKM stages while others progress more slowly, and the use of newer therapies with multiple effects in CKM syndrome, including improving metabolic factors such as pain relief, reducing type 2 diabetes and kidney disease.